Different patterns of clonal evolution among different sarcoma subtypes followed for up to 25 years
Open Access
- 10 September 2018
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 3662
Abstract
To compare clonal evolution in tumors arising through different mechanisms, we selected three types of sarcoma—amplicon-driven well-differentiated liposarcoma (WDLS), gene fusion-driven myxoid liposarcoma (MLS), and sarcomas with complex genomes (CXS)—and assessed the dynamics of chromosome and nucleotide level mutations by cytogenetics, SNP array analysis and whole-exome sequencing. Here we show that the extensive single-cell variation in WDLS has minor impact on clonal key amplicons in chromosome 12. In addition, only a few of the single nucleotide variants in WDLS were present in more than one lesion, suggesting that such mutations are of little significance in tumor development. MLS displays few mutations other than the FUS-DDIT3 fusion, and the primary tumor is genetically sometimes much more complex than its relapses, whereas CXS in general shows a gradual increase of both nucleotide- and chromosome–level mutations, similar to what has been described in carcinomas.Keywords
Funding Information
- Cancerfonden (CAN2017/269)
This publication has 43 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samplesNature Biotechnology, 2013
- Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairsBioinformatics, 2012
- Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneityGenome Biology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Concomitant deletions of tumor suppressor genes MEN1 and AIP are essential for the pathogenesis of the brown fat tumor hibernomaProceedings of the National Academy of Sciences, 2010
- Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyNature Genetics, 2010
- Clinical and Biological Significance of CDK4 Amplification in Well-Differentiated and Dedifferentiated LiposarcomasClinical Cancer Research, 2009
- Global Genomic Characterization of Acute Lymphoblastic LeukemiaSeminars in Hematology, 2009
- Intratumor versus intertumor heterogeneity in gene expression profiles of soft‐tissue sarcomasGenes, Chromosomes and Cancer, 2005